Evaluation of the effect of oral levofloxacin on chronic endometritis in patients

Evaluation of the effect of oral levofloxacin on refractory chronic endometritis in patients with recurrent implant failure

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220413054524N1

Enrollment

Registered

2022-05-09

Start date

2022-04-04

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometritis. Inflammatory disease of uterus, unspecified

Interventions

Intervention 1: Intervention group: Use levofloxacin for 7 days and have a biopsy for endometritis in the next menstrual cycle. Intervention 2: Control group: They will receive a placebo.

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Females with chronic endometritis with fetal transfer failure confirmed by histology using histology

Exclusion criteria

Exclusion criteria: Sensitivity to doxycycline Allergy to metronidazole Glucose 6 phosphate dehydrogenase deficiency

Design outcomes

Primary

Measure	Time frame
Endometritis. Timepoint: Before the intervention and the next menstrual cycle. Method of measurement: Perform a biopsy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Bakhiyari

Shahre-kord University of Medical Sciences

shghyeghbakhtiyari@gmail.com+98 38 3222 1943

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026